Top Health Care Stocks
Health care stocks were finishing back near their session highs, with the NYSE Health Care Index rising more than 2.0% while shares of health care companies in the S&P 500 were up over 1.8% as a group.
In company news, Bellerophon Therapeutics ( BLPH ) rallied Wednesday after presenting Phase III data showing its INOpulse chemical-delivery device widened blood vessels in patients with high blood pressure associated with chronic obstructive pulmonary disease.
The trial sought to measure how well nitric oxide inhaled from an INOpulse device worked to improve respiratory and cardiovascular function in older adult patients with pulmonary hypertension and COPD who have been using oxygen therapy for an extended period.
According to the company, all six of the trial participants demonstrated increased volume in the blood vessels of the lungs after inhaling an acute dose of nitric oxide while also preserving oxygen saturation. The patients also reported feeling better following the treatment.
BLPH shares were up 28% this afternoon at $5.27 apiece, earlier climbing to a session high of $6.03 a share.
In other sector news,
(+) MDWD, U.S. Biomedical Advanced Research and Development Authority awards five-year contract worth up to $112 mln, including $24 mln to support work needed for FDA approval of NexoBrid and $16 mln for NexoBrid procurement.
(-) HAE, Brian Concannon resigns as president and CEO, effective immediately, although he will remain with company until Oct. 31 to ensure a smooth transition. Company selects board member Ron Gelbman to be interim CEO.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.